


One-Stop Preclinical Pharmacology for Metabolic, Hepatic & Endocrine Diseases
Our Platform offers one-stop preclinical pharmacology services across metabolic, hepatic, and endocrine diseases — including obesity, diabetes, MASH, and beyond. With study-ready models ranging from DIO rodents to obese NHPs, end-to-end efficacy services, and a parallel database and biobank, we empower your drug development from target to clinic.
Download the brochure to explore our full capabilities and see how we can support your program.